Functional Genetics, Inc. - Using Innovative Science to Develop New Therapeutics for Infectious Diseases

Copyright © 2009 Functional Genetics Inc. All rights reserved.

Functional Genetics, Inc. (FGI) is focused on developing new antiviral drugs that can prevent or treat infections by a broad-spectrum of viruses. Our commercial product focus has targeted three broad areas: Respiratory viruses (RSV, Influenza), Hepatitis viruses (HBV, HCV) and Sexually-transmitted viruses (HIV, Herpes). Our government product focus is on the hemorrhagic fever viruses (Ebola, Marburg, Lassa).

FGI commenced operations in 2001 to capitalize on a new technology for target discovery, Random Homozygous Gene Perturbation (RHGP). RHGP combines state-of-the art molecular biology and functional understanding of cell behavior to find rapid and elegant solutions to many complex biological problems.